Find clinical trials for Breast Cancer in Barcelona, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Barcelona, CT, ESP:
adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...
Phase 2
Barcelona, Spain and 72 other locations
in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-low breast cancer with active brain metastases.This study will ana...
Phase 2
Barcelona, Spain and 11 other locations
A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...
Phase 1
Barcelona, Spain and 8 other locations
-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this stud...
Phase 3
Barcelona, Spain and 52 other locations
participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...
Phase 2
Barcelona, Spain and 31 other locations
participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...
Phase 1, Phase 2
Barcelona, Spain and 22 other locations
the primary and metastatic (or relapsed) tumor will be collected for central analyses, together with blood, serum and plasma samples. Any s ...
Barcelona, Spain and 51 other locations
This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...
Phase 2
Barcelona, Spain and 36 other locations
A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...
Phase 1
Barcelona, Spain and 16 other locations
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Barcelona, Spain and 71 other locations
Clinical trials
Research sites
Resources
Legal